Home
Home

biotech

JPM kicks off with fevered focus on the next big biotech deal

JPM kicks off with fevered focus on the next big biotech deal
Fierce Biotech

Biotech drug makers aim to extend brand dominance

Biotech drug makers aim to extend brand dominance
Reuters

Amgen, big biotechs poised for big year of deals, analysts say

Amgen, big biotechs poised for big year of deals, analysts say
Fierce Pharma

Biotech’s Glass Half Full for 2012

Biotech’s Glass Half Full for 2012
Life Sci VC

Five Predictions For Biotech And Medicine In 2012

Five Predictions For Biotech And Medicine In 2012
Forbes

A Look Back at 2010-2011 Class of Biotech IPOs: Not Dead Yet

A Look Back at 2010-2011 Class of Biotech IPOs: Not Dead Yet
Forbes

The Worst Biotech CEO of 2011 Is ...

The Worst Biotech CEO of 2011 Is ...
TheStreet.com

Hungry biotechs make better partners for Big Pharma

Hungry biotechs make better partners for Big Pharma
Fierce Biotech

Solving Biotech's "Asymmetry of Maturity" Challenge

Solving Biotech's "Asymmetry of Maturity" Challenge
Forbes

Icahn’s $2 Billion Man Starts Fund as Activists Shun Biotech

Icahn’s $2 Billion Man Starts Fund as Activists Shun Biotech
Bloomberg